NCT06979726View on ClinicalTrials.gov

Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Heart FailureVolume Overload

Interventions

DRUG

Lasix ONYU

Providing subcutaneous furosemide to eligible patients

All Listed Sponsors

collaborator

SQ Innovation, Inc.

INDUSTRY

lead

University of Florida

OTHER